BioAtla, Inc.
NASDAQBCAB short interest surges 37% in one week to 0.18% of float, as stock plummets 21% and cost to borrow falls sharply to 5.36%.
Snapshot as of 8 May 2026
No long-form analysis yet for BCAB. Pulse alerts and the live data picture are available on ORTEX.
Open BCAB on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BCAB — free to start on ORTEX.
Sign up for free →Open BCAB on ORTEX